Associates of Cape Cod, bioMérieux, COPAN, METTLER TOLEDO, Reading Scientific Services Limited, Veltek Associates
James Drinkwater, Chairman, Pharmaceutical and Healthcare Science Society
Olivier Chancel, Sterility and Aseptic Practices Expert, Boehringer Ingelheim
Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025.
At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing updates to meet regulatory requirements.
Join us at SMi’s 9th Annual Pharmaceutical Microbiology Conference to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology.
Conference & Workshop Day GBP 2398.00
Conference only GBP 1499.00
Workshop Day only GBP 899.00
Speakers: CHAIR: James Drinkwater, Chairman, Pharmaceutical and Healthcare Science Society, CHAIR: Olivier Chancel, Sterility and Aseptic Practices Expert, Boehringer Ingelheim, Ian Symonds, Director, Pharmaceutical Consultant, SDA Pharma, Luis Meirinhos-Soares, GMP Inspector, Infarmed IP, Sylvanie Cassard Guilloux, Global Solution Manager, bioMerieux, Ingo Spreitzer, Deputy Head Section Microbial Safety, Paul Ehrlich Institut, Sonia Allibardi, Market Access Manager, Copan Group, Gabriele Savoldi, Business Development Manager, Copan Group, Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca, Sophie Drinkwater, QC Technical Officer, AstraZeneca, Michael Song, Senior Manager, AstraZeneca, Maria Jose Zafra-Domene, Microbiology QC Team Leader, MeiraGTx, Jim Polarine, Senior Technical Service Manager, STERIS Corporation, James Cannon, Head of OEM and Markets, Mettler Toledo, David Elder, Principal Consultant, David P Elder Consultancy, Pratixa Patel, Senior Director, Microbiological and Stability Sciences, GSK, Veronika Wills, Manager, Technical Services, Associates of Cape Cod, Jason McGuire, VP, Quality and Regulatory, Fagron, Ian Symonds, Director/Pharmaceutical Consultant, SDA Pharma, Felix Alejandro Montero Julian, Scientific Director, bioMerieux, Stefane Schweicher, Business Development Manager Endotoxin NEC, bioMerieux